# FDA Inspection 1201325 - Dana-Farber Cancer Institute, Office of Human Research Studies IRB - February 23, 2023

Source: https://www.keypedia.com/records/fda_inspections/dana-farber-cancer-institute-office-of-human-research-studies-irb/b89003d1-72b6-4b0b-b0eb-5d89b7cf8fc8
Source feed: FDA_Inspections

> FDA Inspection 1201325 for Dana-Farber Cancer Institute, Office of Human Research Studies IRB on February 23, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1201325
- Company Name: Dana-Farber Cancer Institute, Office of Human Research Studies IRB
- Inspection Date: 2023-02-23
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Devices

## Related Documents

- [FDA Inspection 1201325 - 2023-02-23](https://www.keypedia.com/records/fda_inspections/dana-farber-cancer-institute-office-of-human-research-studies-irb/5d5b4113-d7a9-4685-996e-e689863e550f)
- [FDA Inspection 1201325 - 2023-02-23](https://www.keypedia.com/records/fda_inspections/dana-farber-cancer-institute-office-of-human-research-studies-irb/c7fa9014-b864-4174-ba96-65a88d76556b)
- [FDA Inspection 995638 - 2016-11-04](https://www.keypedia.com/records/fda_inspections/dana-farber-cancer-institute-office-of-human-research-studies-irb/aa656329-3dc2-4e24-8f95-42d405f2bc2f)
- [FDA Inspection 656660 - 2010-03-25](https://www.keypedia.com/records/fda_inspections/dana-farber-cancer-institute-office-of-human-research-studies-irb/7a354df2-90bb-493f-8c84-9a69aae8d513)

Company: https://www.keypedia.com/companies/dana-farber-cancer-institute-office-of-human-research-studies-irb/accf04d4-ff49-488a-b170-0cbd5e88d69a